These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 19679590

  • 21. Novel oral anticoagulants--key messages for the angiologist.
    Haas S, Spannagl M, Schellong SM.
    Vasa; 2012 May; 41(3):177-91. PubMed ID: 22565619
    [Abstract] [Full Text] [Related]

  • 22. Thromboembolic prophylaxis in orthopedic surgery using dabigatran: an oral direct thrombin inhibitor.
    Garza R, Huo MH.
    Expert Rev Cardiovasc Ther; 2012 Apr; 10(4):423-7. PubMed ID: 22458575
    [Abstract] [Full Text] [Related]

  • 23. Dabigatran etexilate (Pradaxa)--a new oral anticoagulant.
    Med Lett Drugs Ther; 2010 Nov 15; 52(1351):89-90. PubMed ID: 21068702
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Dabigatran etexilate, a new oral direct thrombin inhibitor, for stroke prevention in patients with atrial fibrillation.
    Siddiqui FM, Qureshi AI.
    Expert Opin Pharmacother; 2010 Jun 15; 11(8):1403-11. PubMed ID: 20446854
    [Abstract] [Full Text] [Related]

  • 27. Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.
    RE-MOBILIZE Writing CommitteeMcMaster University Medical Centre, Ontario, Canada., Ginsberg JS, Davidson BL, Comp PC, Francis CW, Friedman RJ, Huo MH, Lieberman JR, Muntz JE, Raskob GE, Clements ML, Hantel S, Schnee JM, Caprini JA.
    J Arthroplasty; 2009 Jan 15; 24(1):1-9. PubMed ID: 18534438
    [Abstract] [Full Text] [Related]

  • 28. Implications of new anticoagulants in primary practice.
    Perez A, Eraso LH, Merli GJ.
    Int J Clin Pract; 2013 Feb 15; 67(2):139-56. PubMed ID: 23305476
    [Abstract] [Full Text] [Related]

  • 29. Hospital-based clinical implications of the novel oral anticoagulant, dabigatran etexilate, in daily practice.
    Wilcox R, Pendleton RC, Smock KJ, Rodgers GM.
    Hosp Pract (1995); 2011 Aug 15; 39(3):23-34. PubMed ID: 21881389
    [Abstract] [Full Text] [Related]

  • 30. Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty.
    Borris LC.
    Arch Orthop Trauma Surg; 2010 May 15; 130(5):583-9. PubMed ID: 19565250
    [Abstract] [Full Text] [Related]

  • 31. New oral anticoagulants in atrial fibrillation.
    Turpie AG.
    Eur Heart J; 2008 Jan 15; 29(2):155-65. PubMed ID: 18096568
    [Abstract] [Full Text] [Related]

  • 32. Dabigatran etexilate: a possible replacement for heparinoids and vitamin K antagonists?
    Guay DR.
    Hosp Pract (1995); 2011 Feb 15; 39(1):105-25. PubMed ID: 21441766
    [Abstract] [Full Text] [Related]

  • 33. Dabigatran etexilate: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery.
    Burness CB, McKeage K.
    Drugs; 2012 May 07; 72(7):963-86. PubMed ID: 22564134
    [Abstract] [Full Text] [Related]

  • 34. Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary.
    Waks JW, Zimetbaum PJ.
    Expert Rev Cardiovasc Ther; 2013 Nov 07; 11(11):1461-71. PubMed ID: 24147516
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [New anticoagulants - direct thrombin inhibitors].
    Brand B, Graf L.
    Ther Umsch; 2012 Nov 07; 69(11):643-9. PubMed ID: 23117667
    [Abstract] [Full Text] [Related]

  • 37. Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves.
    McKellar SH, Abel S, Camp CL, Suri RM, Ereth MH, Schaff HV.
    J Thorac Cardiovasc Surg; 2011 Jun 07; 141(6):1410-6. PubMed ID: 21429525
    [Abstract] [Full Text] [Related]

  • 38. New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders.
    Dahl OE.
    Vasc Health Risk Manag; 2012 Jun 07; 8():45-57. PubMed ID: 22323896
    [Abstract] [Full Text] [Related]

  • 39. Dabigatran etexilate, a thrombin inhibitor for the prevention of venous thromboembolism and stroke.
    Ieko M.
    Curr Opin Investig Drugs; 2007 Sep 07; 8(9):758-68. PubMed ID: 17729188
    [Abstract] [Full Text] [Related]

  • 40. Dabigatran vs. low molecular weight heparin in preventing venous thromboembolism after elective hip and knee arthroplasty: evaluation of selected clinical parameters.
    Mrozik D, Jackiewicz A, Krzemiński M.
    Pol Orthop Traumatol; 2012 Oct 25; 77():111-4. PubMed ID: 23306297
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.